Search Result "anti-anaplastic lymphoma kinase (ALK)"
Research Progress on the Drug Resistance of ALK Kinase Inhibitors
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 14 Year: 2022 Page: 2456-2475
Author(s): Zhen Li,Fang Liu,Shuang Wu,Shi Ding,Ye Chen
A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements andMutations: Implications for Gastric Carcinogenesis and Target Therapy
Journal: Current Protein & Peptide Science
Volume: 25 Issue: 7 Year: 2024 Page: 539-552
Author(s): Felipe Pantoja Mesquita,Luina Benevides Lima,Emerson Lucena da Silva,Pedro Filho Noronha Souza,Maria Elisabete Amaral de Moraes,Rommel Mario Rodrigues Burbano,Raquel Carvalho Montenegro
Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 6 Year: 2017 Page: 590-613
Author(s): Jingru Liu,Shutao Ma
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2010 Page: 236-249
Author(s): Mangeng Cheng, Gregory R. Ott
MET and ALK as Targets for the Treatment of NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3914-3932
Author(s): Capelletti M,Gelsomino F.,Tiseo M.
Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 2 Year: 2018 Page: 209-223
Author(s): Theodosis Kalamatianos,Despoina Denekou,George Stranjalis,Evangelia Papadimitriou
Crizotinib Versus Chemotherapy on ALK-positive NSCLC: A Systematic Review of Efficacy and Safety
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 41-49
Author(s): Mingxia Wang,Guanqi Wang,Haiyan Ma,Baoen Shan
EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 4 Year: 2016 Page: 393-400
Author(s): Ramon Andrade De Mello,Davi J. J. Liu,Pedro N. Aguiar,Hakaru Tadokoro
Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 2 Year: 2007 Page: 103-110
Author(s): Sonali M. Smith
Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Related Bridgehead Nitrogen Heterocycles in Medicinal Chemistry
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 8 Year: 2013 Page: 1528-1548
Author(s): Yu'ning Song,Peng Zhan,Qingzhu Zhang,Xinyong Liu